Recurrent internal tandem duplications of BCOR in clear cell sarcoma of the kidney.

TitleRecurrent internal tandem duplications of BCOR in clear cell sarcoma of the kidney.
Publication TypeJournal Article
Year of Publication2015
AuthorsRoy, A, Kumar, V, Zorman, B, Fang, E, Haines, KM, Doddapaneni, HV, Hampton, OA, White, S, Bavle, AA, Patel, NR, Eldin, KW, M Hicks, J, Rakheja, D, Leavey, PJ, Skapek, SX, Amatruda, JF, Nuchtern, JG, Chintagumpala, MM, Wheeler, DA, Plon, SE, Sumazin, P, D Parsons, W
JournalNat Commun
Volume6
Pagination8891
Date Published2015 Nov 17
ISSN2041-1723
KeywordsCase-Control Studies, Child, Preschool, Female, Gene Duplication, Gene Expression Profiling, Gene Expression Regulation, Neoplastic, Humans, Immunoblotting, Immunohistochemistry, Infant, Kidney Neoplasms, Male, Mutation, Neoplasm Recurrence, Local, Proto-Oncogene Proteins, Repressor Proteins, Reverse Transcriptase Polymerase Chain Reaction, RNA, Messenger, Sarcoma, Clear Cell, Sequence Analysis, DNA, Sequence Analysis, RNA, Tandem Repeat Sequences
Abstract

The X-linked BCL-6 co-repressor (BCOR) gene encodes a key constituent of a variant polycomb repressive complex (PRC) that is mutated or translocated in human cancers. Here we report on the identification of somatic internal tandem duplications (ITDs) clustering in the C terminus of BCOR in 23 of 27 (85%) pediatric clear cell sarcomas of the kidney (CCSK) from two independent cohorts. We profile CCSK tumours using a combination of whole-exome, transcriptome and targeted sequencing. Identical ITD mutations are found in primary and relapsed tumour pairs but not in adjacent normal kidney or blood. Mutant BCOR transcripts and proteins are markedly upregulated in ITD-positive tumours. Transcriptome analysis of ITD-positive CCSKs reveals enrichment for PRC2-regulated genes and similarity to undifferentiated sarcomas harbouring BCOR-CCNB3 fusions. The discovery of recurrent BCOR ITDs defines a major oncogenic event in this childhood sarcoma with significant implications for diagnostic and therapeutic approaches to this tumour.

DOI10.1038/ncomms9891
Alternate JournalNat Commun
PubMed ID26573325
PubMed Central IDPMC4660214
Grant ListU01 HG006485 / HG / NHGRI NIH HHS / United States